Global Biologic Medication in COVID-19 Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to China's clinical trials of COVID-19 treatment, the number of chemical drugs accounted for the highest proportion, followed by biological drugs, cell therapy, vaccines, and traditional Chinese medicine. Among the biological drugs, IL-6 related monoclonal antibodies (anti-inflammatory) account for the largest proportion, including tocilizumab and Sarilumab. This report focuses on the investigation and analysis of biologic medication and predicts the future market development of biopharmaceuticals under the influence of COVID-19. Biological drugs are mainly divided into two categories: neutralizing antibodies and anti-inflammatory drugs. The main subdivisions include: IL-6, C5a, CD147, PD-1 and Interferon (beta-1a), etc.
According to our (Global Info Research) latest study, the global Biologic Medication in COVID-19 market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Biologic Medication in COVID-19 market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Biologic Medication in COVID-19 market size and forecasts, in consumption value ($ Million), 2018-2029
Global Biologic Medication in COVID-19 market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Biologic Medication in COVID-19 market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Biologic Medication in COVID-19 market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biologic Medication in COVID-19
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biologic Medication in COVID-19 market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Sanofi, Novartis, Merck and Bayer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Biologic Medication in COVID-19 market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Biologic Medication in COVID-19 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biologic Medication in COVID-19, with revenue, gross margin and global market share of Biologic Medication in COVID-19 from 2018 to 2023.
Chapter 3, the Biologic Medication in COVID-19 competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Biologic Medication in COVID-19 market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Biologic Medication in COVID-19.
Chapter 13, to describe Biologic Medication in COVID-19 research findings and conclusion.
According to our (Global Info Research) latest study, the global Biologic Medication in COVID-19 market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Biologic Medication in COVID-19 market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Biologic Medication in COVID-19 market size and forecasts, in consumption value ($ Million), 2018-2029
Global Biologic Medication in COVID-19 market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Biologic Medication in COVID-19 market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Biologic Medication in COVID-19 market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biologic Medication in COVID-19
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biologic Medication in COVID-19 market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Sanofi, Novartis, Merck and Bayer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Biologic Medication in COVID-19 market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Neutralizing Antibodies
- Anti-inflammatory Drugs
- COVID-19
- Influenza
- Malaria
- Others
- Roche
- Sanofi
- Novartis
- Merck
- Bayer
- Shutaishen
- Biogen
- Regeneron Pharmaceuticals
- Vir Biotech
- Junshi Biosciences
- Anke Biotechnology
- OncoImmune
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Biologic Medication in COVID-19 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biologic Medication in COVID-19, with revenue, gross margin and global market share of Biologic Medication in COVID-19 from 2018 to 2023.
Chapter 3, the Biologic Medication in COVID-19 competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Biologic Medication in COVID-19 market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Biologic Medication in COVID-19.
Chapter 13, to describe Biologic Medication in COVID-19 research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Biologic Medication in COVID-19
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biologic Medication in COVID-19 by Type
1.3.1 Overview: Global Biologic Medication in COVID-19 Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Biologic Medication in COVID-19 Consumption Value Market Share by Type in 2022
1.3.3 Neutralizing Antibodies
1.3.4 Anti-inflammatory Drugs
1.4 Global Biologic Medication in COVID-19 Market by Application
1.4.1 Overview: Global Biologic Medication in COVID-19 Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 COVID-19
1.4.3 Influenza
1.4.4 Malaria
1.4.5 Others
1.5 Global Biologic Medication in COVID-19 Market Size & Forecast
1.6 Global Biologic Medication in COVID-19 Market Size and Forecast by Region
1.6.1 Global Biologic Medication in COVID-19 Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Biologic Medication in COVID-19 Market Size by Region, (2018-2029)
1.6.3 North America Biologic Medication in COVID-19 Market Size and Prospect (2018-2029)
1.6.4 Europe Biologic Medication in COVID-19 Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Biologic Medication in COVID-19 Market Size and Prospect (2018-2029)
1.6.6 South America Biologic Medication in COVID-19 Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Biologic Medication in COVID-19 Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Biologic Medication in COVID-19 Product and Solutions
2.1.4 Roche Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Biologic Medication in COVID-19 Product and Solutions
2.2.4 Sanofi Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Biologic Medication in COVID-19 Product and Solutions
2.3.4 Novartis Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Biologic Medication in COVID-19 Product and Solutions
2.4.4 Merck Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck Recent Developments and Future Plans
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Biologic Medication in COVID-19 Product and Solutions
2.5.4 Bayer Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bayer Recent Developments and Future Plans
2.6 Shutaishen
2.6.1 Shutaishen Details
2.6.2 Shutaishen Major Business
2.6.3 Shutaishen Biologic Medication in COVID-19 Product and Solutions
2.6.4 Shutaishen Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Shutaishen Recent Developments and Future Plans
2.7 Biogen
2.7.1 Biogen Details
2.7.2 Biogen Major Business
2.7.3 Biogen Biologic Medication in COVID-19 Product and Solutions
2.7.4 Biogen Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Biogen Recent Developments and Future Plans
2.8 Regeneron Pharmaceuticals
2.8.1 Regeneron Pharmaceuticals Details
2.8.2 Regeneron Pharmaceuticals Major Business
2.8.3 Regeneron Pharmaceuticals Biologic Medication in COVID-19 Product and Solutions
2.8.4 Regeneron Pharmaceuticals Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Regeneron Pharmaceuticals Recent Developments and Future Plans
2.9 Vir Biotech
2.9.1 Vir Biotech Details
2.9.2 Vir Biotech Major Business
2.9.3 Vir Biotech Biologic Medication in COVID-19 Product and Solutions
2.9.4 Vir Biotech Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Vir Biotech Recent Developments and Future Plans
2.10 Junshi Biosciences
2.10.1 Junshi Biosciences Details
2.10.2 Junshi Biosciences Major Business
2.10.3 Junshi Biosciences Biologic Medication in COVID-19 Product and Solutions
2.10.4 Junshi Biosciences Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Junshi Biosciences Recent Developments and Future Plans
2.11 Anke Biotechnology
2.11.1 Anke Biotechnology Details
2.11.2 Anke Biotechnology Major Business
2.11.3 Anke Biotechnology Biologic Medication in COVID-19 Product and Solutions
2.11.4 Anke Biotechnology Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Anke Biotechnology Recent Developments and Future Plans
2.12 OncoImmune
2.12.1 OncoImmune Details
2.12.2 OncoImmune Major Business
2.12.3 OncoImmune Biologic Medication in COVID-19 Product and Solutions
2.12.4 OncoImmune Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 OncoImmune Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biologic Medication in COVID-19 Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Biologic Medication in COVID-19 by Company Revenue
3.2.2 Top 3 Biologic Medication in COVID-19 Players Market Share in 2022
3.2.3 Top 6 Biologic Medication in COVID-19 Players Market Share in 2022
3.3 Biologic Medication in COVID-19 Market: Overall Company Footprint Analysis
3.3.1 Biologic Medication in COVID-19 Market: Region Footprint
3.3.2 Biologic Medication in COVID-19 Market: Company Product Type Footprint
3.3.3 Biologic Medication in COVID-19 Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biologic Medication in COVID-19 Consumption Value and Market Share by Type (2018-2023)
4.2 Global Biologic Medication in COVID-19 Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biologic Medication in COVID-19 Consumption Value Market Share by Application (2018-2023)
5.2 Global Biologic Medication in COVID-19 Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Biologic Medication in COVID-19 Consumption Value by Type (2018-2029)
6.2 North America Biologic Medication in COVID-19 Consumption Value by Application (2018-2029)
6.3 North America Biologic Medication in COVID-19 Market Size by Country
6.3.1 North America Biologic Medication in COVID-19 Consumption Value by Country (2018-2029)
6.3.2 United States Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
6.3.3 Canada Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
6.3.4 Mexico Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Biologic Medication in COVID-19 Consumption Value by Type (2018-2029)
7.2 Europe Biologic Medication in COVID-19 Consumption Value by Application (2018-2029)
7.3 Europe Biologic Medication in COVID-19 Market Size by Country
7.3.1 Europe Biologic Medication in COVID-19 Consumption Value by Country (2018-2029)
7.3.2 Germany Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
7.3.3 France Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
7.3.5 Russia Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
7.3.6 Italy Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biologic Medication in COVID-19 Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Biologic Medication in COVID-19 Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Biologic Medication in COVID-19 Market Size by Region
8.3.1 Asia-Pacific Biologic Medication in COVID-19 Consumption Value by Region (2018-2029)
8.3.2 China Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
8.3.3 Japan Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
8.3.4 South Korea Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
8.3.5 India Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
8.3.7 Australia Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Biologic Medication in COVID-19 Consumption Value by Type (2018-2029)
9.2 South America Biologic Medication in COVID-19 Consumption Value by Application (2018-2029)
9.3 South America Biologic Medication in COVID-19 Market Size by Country
9.3.1 South America Biologic Medication in COVID-19 Consumption Value by Country (2018-2029)
9.3.2 Brazil Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
9.3.3 Argentina Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biologic Medication in COVID-19 Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Biologic Medication in COVID-19 Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Biologic Medication in COVID-19 Market Size by Country
10.3.1 Middle East & Africa Biologic Medication in COVID-19 Consumption Value by Country (2018-2029)
10.3.2 Turkey Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
10.3.4 UAE Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Biologic Medication in COVID-19 Market Drivers
11.2 Biologic Medication in COVID-19 Market Restraints
11.3 Biologic Medication in COVID-19 Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Biologic Medication in COVID-19 Industry Chain
12.2 Biologic Medication in COVID-19 Upstream Analysis
12.3 Biologic Medication in COVID-19 Midstream Analysis
12.4 Biologic Medication in COVID-19 Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Biologic Medication in COVID-19
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biologic Medication in COVID-19 by Type
1.3.1 Overview: Global Biologic Medication in COVID-19 Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Biologic Medication in COVID-19 Consumption Value Market Share by Type in 2022
1.3.3 Neutralizing Antibodies
1.3.4 Anti-inflammatory Drugs
1.4 Global Biologic Medication in COVID-19 Market by Application
1.4.1 Overview: Global Biologic Medication in COVID-19 Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 COVID-19
1.4.3 Influenza
1.4.4 Malaria
1.4.5 Others
1.5 Global Biologic Medication in COVID-19 Market Size & Forecast
1.6 Global Biologic Medication in COVID-19 Market Size and Forecast by Region
1.6.1 Global Biologic Medication in COVID-19 Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Biologic Medication in COVID-19 Market Size by Region, (2018-2029)
1.6.3 North America Biologic Medication in COVID-19 Market Size and Prospect (2018-2029)
1.6.4 Europe Biologic Medication in COVID-19 Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Biologic Medication in COVID-19 Market Size and Prospect (2018-2029)
1.6.6 South America Biologic Medication in COVID-19 Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Biologic Medication in COVID-19 Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Biologic Medication in COVID-19 Product and Solutions
2.1.4 Roche Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Biologic Medication in COVID-19 Product and Solutions
2.2.4 Sanofi Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Biologic Medication in COVID-19 Product and Solutions
2.3.4 Novartis Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Biologic Medication in COVID-19 Product and Solutions
2.4.4 Merck Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck Recent Developments and Future Plans
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Biologic Medication in COVID-19 Product and Solutions
2.5.4 Bayer Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bayer Recent Developments and Future Plans
2.6 Shutaishen
2.6.1 Shutaishen Details
2.6.2 Shutaishen Major Business
2.6.3 Shutaishen Biologic Medication in COVID-19 Product and Solutions
2.6.4 Shutaishen Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Shutaishen Recent Developments and Future Plans
2.7 Biogen
2.7.1 Biogen Details
2.7.2 Biogen Major Business
2.7.3 Biogen Biologic Medication in COVID-19 Product and Solutions
2.7.4 Biogen Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Biogen Recent Developments and Future Plans
2.8 Regeneron Pharmaceuticals
2.8.1 Regeneron Pharmaceuticals Details
2.8.2 Regeneron Pharmaceuticals Major Business
2.8.3 Regeneron Pharmaceuticals Biologic Medication in COVID-19 Product and Solutions
2.8.4 Regeneron Pharmaceuticals Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Regeneron Pharmaceuticals Recent Developments and Future Plans
2.9 Vir Biotech
2.9.1 Vir Biotech Details
2.9.2 Vir Biotech Major Business
2.9.3 Vir Biotech Biologic Medication in COVID-19 Product and Solutions
2.9.4 Vir Biotech Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Vir Biotech Recent Developments and Future Plans
2.10 Junshi Biosciences
2.10.1 Junshi Biosciences Details
2.10.2 Junshi Biosciences Major Business
2.10.3 Junshi Biosciences Biologic Medication in COVID-19 Product and Solutions
2.10.4 Junshi Biosciences Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Junshi Biosciences Recent Developments and Future Plans
2.11 Anke Biotechnology
2.11.1 Anke Biotechnology Details
2.11.2 Anke Biotechnology Major Business
2.11.3 Anke Biotechnology Biologic Medication in COVID-19 Product and Solutions
2.11.4 Anke Biotechnology Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Anke Biotechnology Recent Developments and Future Plans
2.12 OncoImmune
2.12.1 OncoImmune Details
2.12.2 OncoImmune Major Business
2.12.3 OncoImmune Biologic Medication in COVID-19 Product and Solutions
2.12.4 OncoImmune Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 OncoImmune Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biologic Medication in COVID-19 Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Biologic Medication in COVID-19 by Company Revenue
3.2.2 Top 3 Biologic Medication in COVID-19 Players Market Share in 2022
3.2.3 Top 6 Biologic Medication in COVID-19 Players Market Share in 2022
3.3 Biologic Medication in COVID-19 Market: Overall Company Footprint Analysis
3.3.1 Biologic Medication in COVID-19 Market: Region Footprint
3.3.2 Biologic Medication in COVID-19 Market: Company Product Type Footprint
3.3.3 Biologic Medication in COVID-19 Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biologic Medication in COVID-19 Consumption Value and Market Share by Type (2018-2023)
4.2 Global Biologic Medication in COVID-19 Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biologic Medication in COVID-19 Consumption Value Market Share by Application (2018-2023)
5.2 Global Biologic Medication in COVID-19 Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Biologic Medication in COVID-19 Consumption Value by Type (2018-2029)
6.2 North America Biologic Medication in COVID-19 Consumption Value by Application (2018-2029)
6.3 North America Biologic Medication in COVID-19 Market Size by Country
6.3.1 North America Biologic Medication in COVID-19 Consumption Value by Country (2018-2029)
6.3.2 United States Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
6.3.3 Canada Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
6.3.4 Mexico Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Biologic Medication in COVID-19 Consumption Value by Type (2018-2029)
7.2 Europe Biologic Medication in COVID-19 Consumption Value by Application (2018-2029)
7.3 Europe Biologic Medication in COVID-19 Market Size by Country
7.3.1 Europe Biologic Medication in COVID-19 Consumption Value by Country (2018-2029)
7.3.2 Germany Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
7.3.3 France Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
7.3.5 Russia Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
7.3.6 Italy Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biologic Medication in COVID-19 Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Biologic Medication in COVID-19 Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Biologic Medication in COVID-19 Market Size by Region
8.3.1 Asia-Pacific Biologic Medication in COVID-19 Consumption Value by Region (2018-2029)
8.3.2 China Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
8.3.3 Japan Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
8.3.4 South Korea Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
8.3.5 India Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
8.3.7 Australia Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Biologic Medication in COVID-19 Consumption Value by Type (2018-2029)
9.2 South America Biologic Medication in COVID-19 Consumption Value by Application (2018-2029)
9.3 South America Biologic Medication in COVID-19 Market Size by Country
9.3.1 South America Biologic Medication in COVID-19 Consumption Value by Country (2018-2029)
9.3.2 Brazil Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
9.3.3 Argentina Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biologic Medication in COVID-19 Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Biologic Medication in COVID-19 Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Biologic Medication in COVID-19 Market Size by Country
10.3.1 Middle East & Africa Biologic Medication in COVID-19 Consumption Value by Country (2018-2029)
10.3.2 Turkey Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
10.3.4 UAE Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Biologic Medication in COVID-19 Market Drivers
11.2 Biologic Medication in COVID-19 Market Restraints
11.3 Biologic Medication in COVID-19 Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Biologic Medication in COVID-19 Industry Chain
12.2 Biologic Medication in COVID-19 Upstream Analysis
12.3 Biologic Medication in COVID-19 Midstream Analysis
12.4 Biologic Medication in COVID-19 Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Biologic Medication in COVID-19 Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Biologic Medication in COVID-19 Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Biologic Medication in COVID-19 Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Biologic Medication in COVID-19 Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Biologic Medication in COVID-19 Product and Solutions
Table 8. Roche Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Roche Recent Developments and Future Plans
Table 10. Sanofi Company Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Biologic Medication in COVID-19 Product and Solutions
Table 13. Sanofi Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Sanofi Recent Developments and Future Plans
Table 15. Novartis Company Information, Head Office, and Major Competitors
Table 16. Novartis Major Business
Table 17. Novartis Biologic Medication in COVID-19 Product and Solutions
Table 18. Novartis Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Novartis Recent Developments and Future Plans
Table 20. Merck Company Information, Head Office, and Major Competitors
Table 21. Merck Major Business
Table 22. Merck Biologic Medication in COVID-19 Product and Solutions
Table 23. Merck Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Merck Recent Developments and Future Plans
Table 25. Bayer Company Information, Head Office, and Major Competitors
Table 26. Bayer Major Business
Table 27. Bayer Biologic Medication in COVID-19 Product and Solutions
Table 28. Bayer Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Bayer Recent Developments and Future Plans
Table 30. Shutaishen Company Information, Head Office, and Major Competitors
Table 31. Shutaishen Major Business
Table 32. Shutaishen Biologic Medication in COVID-19 Product and Solutions
Table 33. Shutaishen Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Shutaishen Recent Developments and Future Plans
Table 35. Biogen Company Information, Head Office, and Major Competitors
Table 36. Biogen Major Business
Table 37. Biogen Biologic Medication in COVID-19 Product and Solutions
Table 38. Biogen Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Biogen Recent Developments and Future Plans
Table 40. Regeneron Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 41. Regeneron Pharmaceuticals Major Business
Table 42. Regeneron Pharmaceuticals Biologic Medication in COVID-19 Product and Solutions
Table 43. Regeneron Pharmaceuticals Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Regeneron Pharmaceuticals Recent Developments and Future Plans
Table 45. Vir Biotech Company Information, Head Office, and Major Competitors
Table 46. Vir Biotech Major Business
Table 47. Vir Biotech Biologic Medication in COVID-19 Product and Solutions
Table 48. Vir Biotech Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Vir Biotech Recent Developments and Future Plans
Table 50. Junshi Biosciences Company Information, Head Office, and Major Competitors
Table 51. Junshi Biosciences Major Business
Table 52. Junshi Biosciences Biologic Medication in COVID-19 Product and Solutions
Table 53. Junshi Biosciences Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Junshi Biosciences Recent Developments and Future Plans
Table 55. Anke Biotechnology Company Information, Head Office, and Major Competitors
Table 56. Anke Biotechnology Major Business
Table 57. Anke Biotechnology Biologic Medication in COVID-19 Product and Solutions
Table 58. Anke Biotechnology Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Anke Biotechnology Recent Developments and Future Plans
Table 60. OncoImmune Company Information, Head Office, and Major Competitors
Table 61. OncoImmune Major Business
Table 62. OncoImmune Biologic Medication in COVID-19 Product and Solutions
Table 63. OncoImmune Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. OncoImmune Recent Developments and Future Plans
Table 65. Global Biologic Medication in COVID-19 Revenue (USD Million) by Players (2018-2023)
Table 66. Global Biologic Medication in COVID-19 Revenue Share by Players (2018-2023)
Table 67. Breakdown of Biologic Medication in COVID-19 by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Biologic Medication in COVID-19, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 69. Head Office of Key Biologic Medication in COVID-19 Players
Table 70. Biologic Medication in COVID-19 Market: Company Product Type Footprint
Table 71. Biologic Medication in COVID-19 Market: Company Product Application Footprint
Table 72. Biologic Medication in COVID-19 New Market Entrants and Barriers to Market Entry
Table 73. Biologic Medication in COVID-19 Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Biologic Medication in COVID-19 Consumption Value (USD Million) by Type (2018-2023)
Table 75. Global Biologic Medication in COVID-19 Consumption Value Share by Type (2018-2023)
Table 76. Global Biologic Medication in COVID-19 Consumption Value Forecast by Type (2024-2029)
Table 77. Global Biologic Medication in COVID-19 Consumption Value by Application (2018-2023)
Table 78. Global Biologic Medication in COVID-19 Consumption Value Forecast by Application (2024-2029)
Table 79. North America Biologic Medication in COVID-19 Consumption Value by Type (2018-2023) & (USD Million)
Table 80. North America Biologic Medication in COVID-19 Consumption Value by Type (2024-2029) & (USD Million)
Table 81. North America Biologic Medication in COVID-19 Consumption Value by Application (2018-2023) & (USD Million)
Table 82. North America Biologic Medication in COVID-19 Consumption Value by Application (2024-2029) & (USD Million)
Table 83. North America Biologic Medication in COVID-19 Consumption Value by Country (2018-2023) & (USD Million)
Table 84. North America Biologic Medication in COVID-19 Consumption Value by Country (2024-2029) & (USD Million)
Table 85. Europe Biologic Medication in COVID-19 Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Europe Biologic Medication in COVID-19 Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Europe Biologic Medication in COVID-19 Consumption Value by Application (2018-2023) & (USD Million)
Table 88. Europe Biologic Medication in COVID-19 Consumption Value by Application (2024-2029) & (USD Million)
Table 89. Europe Biologic Medication in COVID-19 Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Biologic Medication in COVID-19 Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Biologic Medication in COVID-19 Consumption Value by Type (2018-2023) & (USD Million)
Table 92. Asia-Pacific Biologic Medication in COVID-19 Consumption Value by Type (2024-2029) & (USD Million)
Table 93. Asia-Pacific Biologic Medication in COVID-19 Consumption Value by Application (2018-2023) & (USD Million)
Table 94. Asia-Pacific Biologic Medication in COVID-19 Consumption Value by Application (2024-2029) & (USD Million)
Table 95. Asia-Pacific Biologic Medication in COVID-19 Consumption Value by Region (2018-2023) & (USD Million)
Table 96. Asia-Pacific Biologic Medication in COVID-19 Consumption Value by Region (2024-2029) & (USD Million)
Table 97. South America Biologic Medication in COVID-19 Consumption Value by Type (2018-2023) & (USD Million)
Table 98. South America Biologic Medication in COVID-19 Consumption Value by Type (2024-2029) & (USD Million)
Table 99. South America Biologic Medication in COVID-19 Consumption Value by Application (2018-2023) & (USD Million)
Table 100. South America Biologic Medication in COVID-19 Consumption Value by Application (2024-2029) & (USD Million)
Table 101. South America Biologic Medication in COVID-19 Consumption Value by Country (2018-2023) & (USD Million)
Table 102. South America Biologic Medication in COVID-19 Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Middle East & Africa Biologic Medication in COVID-19 Consumption Value by Type (2018-2023) & (USD Million)
Table 104. Middle East & Africa Biologic Medication in COVID-19 Consumption Value by Type (2024-2029) & (USD Million)
Table 105. Middle East & Africa Biologic Medication in COVID-19 Consumption Value by Application (2018-2023) & (USD Million)
Table 106. Middle East & Africa Biologic Medication in COVID-19 Consumption Value by Application (2024-2029) & (USD Million)
Table 107. Middle East & Africa Biologic Medication in COVID-19 Consumption Value by Country (2018-2023) & (USD Million)
Table 108. Middle East & Africa Biologic Medication in COVID-19 Consumption Value by Country (2024-2029) & (USD Million)
Table 109. Biologic Medication in COVID-19 Raw Material
Table 110. Key Suppliers of Biologic Medication in COVID-19 Raw Materials
Table 1. Global Biologic Medication in COVID-19 Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Biologic Medication in COVID-19 Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Biologic Medication in COVID-19 Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Biologic Medication in COVID-19 Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Biologic Medication in COVID-19 Product and Solutions
Table 8. Roche Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Roche Recent Developments and Future Plans
Table 10. Sanofi Company Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Biologic Medication in COVID-19 Product and Solutions
Table 13. Sanofi Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Sanofi Recent Developments and Future Plans
Table 15. Novartis Company Information, Head Office, and Major Competitors
Table 16. Novartis Major Business
Table 17. Novartis Biologic Medication in COVID-19 Product and Solutions
Table 18. Novartis Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Novartis Recent Developments and Future Plans
Table 20. Merck Company Information, Head Office, and Major Competitors
Table 21. Merck Major Business
Table 22. Merck Biologic Medication in COVID-19 Product and Solutions
Table 23. Merck Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Merck Recent Developments and Future Plans
Table 25. Bayer Company Information, Head Office, and Major Competitors
Table 26. Bayer Major Business
Table 27. Bayer Biologic Medication in COVID-19 Product and Solutions
Table 28. Bayer Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Bayer Recent Developments and Future Plans
Table 30. Shutaishen Company Information, Head Office, and Major Competitors
Table 31. Shutaishen Major Business
Table 32. Shutaishen Biologic Medication in COVID-19 Product and Solutions
Table 33. Shutaishen Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Shutaishen Recent Developments and Future Plans
Table 35. Biogen Company Information, Head Office, and Major Competitors
Table 36. Biogen Major Business
Table 37. Biogen Biologic Medication in COVID-19 Product and Solutions
Table 38. Biogen Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Biogen Recent Developments and Future Plans
Table 40. Regeneron Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 41. Regeneron Pharmaceuticals Major Business
Table 42. Regeneron Pharmaceuticals Biologic Medication in COVID-19 Product and Solutions
Table 43. Regeneron Pharmaceuticals Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Regeneron Pharmaceuticals Recent Developments and Future Plans
Table 45. Vir Biotech Company Information, Head Office, and Major Competitors
Table 46. Vir Biotech Major Business
Table 47. Vir Biotech Biologic Medication in COVID-19 Product and Solutions
Table 48. Vir Biotech Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Vir Biotech Recent Developments and Future Plans
Table 50. Junshi Biosciences Company Information, Head Office, and Major Competitors
Table 51. Junshi Biosciences Major Business
Table 52. Junshi Biosciences Biologic Medication in COVID-19 Product and Solutions
Table 53. Junshi Biosciences Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Junshi Biosciences Recent Developments and Future Plans
Table 55. Anke Biotechnology Company Information, Head Office, and Major Competitors
Table 56. Anke Biotechnology Major Business
Table 57. Anke Biotechnology Biologic Medication in COVID-19 Product and Solutions
Table 58. Anke Biotechnology Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Anke Biotechnology Recent Developments and Future Plans
Table 60. OncoImmune Company Information, Head Office, and Major Competitors
Table 61. OncoImmune Major Business
Table 62. OncoImmune Biologic Medication in COVID-19 Product and Solutions
Table 63. OncoImmune Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. OncoImmune Recent Developments and Future Plans
Table 65. Global Biologic Medication in COVID-19 Revenue (USD Million) by Players (2018-2023)
Table 66. Global Biologic Medication in COVID-19 Revenue Share by Players (2018-2023)
Table 67. Breakdown of Biologic Medication in COVID-19 by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Biologic Medication in COVID-19, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 69. Head Office of Key Biologic Medication in COVID-19 Players
Table 70. Biologic Medication in COVID-19 Market: Company Product Type Footprint
Table 71. Biologic Medication in COVID-19 Market: Company Product Application Footprint
Table 72. Biologic Medication in COVID-19 New Market Entrants and Barriers to Market Entry
Table 73. Biologic Medication in COVID-19 Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Biologic Medication in COVID-19 Consumption Value (USD Million) by Type (2018-2023)
Table 75. Global Biologic Medication in COVID-19 Consumption Value Share by Type (2018-2023)
Table 76. Global Biologic Medication in COVID-19 Consumption Value Forecast by Type (2024-2029)
Table 77. Global Biologic Medication in COVID-19 Consumption Value by Application (2018-2023)
Table 78. Global Biologic Medication in COVID-19 Consumption Value Forecast by Application (2024-2029)
Table 79. North America Biologic Medication in COVID-19 Consumption Value by Type (2018-2023) & (USD Million)
Table 80. North America Biologic Medication in COVID-19 Consumption Value by Type (2024-2029) & (USD Million)
Table 81. North America Biologic Medication in COVID-19 Consumption Value by Application (2018-2023) & (USD Million)
Table 82. North America Biologic Medication in COVID-19 Consumption Value by Application (2024-2029) & (USD Million)
Table 83. North America Biologic Medication in COVID-19 Consumption Value by Country (2018-2023) & (USD Million)
Table 84. North America Biologic Medication in COVID-19 Consumption Value by Country (2024-2029) & (USD Million)
Table 85. Europe Biologic Medication in COVID-19 Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Europe Biologic Medication in COVID-19 Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Europe Biologic Medication in COVID-19 Consumption Value by Application (2018-2023) & (USD Million)
Table 88. Europe Biologic Medication in COVID-19 Consumption Value by Application (2024-2029) & (USD Million)
Table 89. Europe Biologic Medication in COVID-19 Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Biologic Medication in COVID-19 Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Biologic Medication in COVID-19 Consumption Value by Type (2018-2023) & (USD Million)
Table 92. Asia-Pacific Biologic Medication in COVID-19 Consumption Value by Type (2024-2029) & (USD Million)
Table 93. Asia-Pacific Biologic Medication in COVID-19 Consumption Value by Application (2018-2023) & (USD Million)
Table 94. Asia-Pacific Biologic Medication in COVID-19 Consumption Value by Application (2024-2029) & (USD Million)
Table 95. Asia-Pacific Biologic Medication in COVID-19 Consumption Value by Region (2018-2023) & (USD Million)
Table 96. Asia-Pacific Biologic Medication in COVID-19 Consumption Value by Region (2024-2029) & (USD Million)
Table 97. South America Biologic Medication in COVID-19 Consumption Value by Type (2018-2023) & (USD Million)
Table 98. South America Biologic Medication in COVID-19 Consumption Value by Type (2024-2029) & (USD Million)
Table 99. South America Biologic Medication in COVID-19 Consumption Value by Application (2018-2023) & (USD Million)
Table 100. South America Biologic Medication in COVID-19 Consumption Value by Application (2024-2029) & (USD Million)
Table 101. South America Biologic Medication in COVID-19 Consumption Value by Country (2018-2023) & (USD Million)
Table 102. South America Biologic Medication in COVID-19 Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Middle East & Africa Biologic Medication in COVID-19 Consumption Value by Type (2018-2023) & (USD Million)
Table 104. Middle East & Africa Biologic Medication in COVID-19 Consumption Value by Type (2024-2029) & (USD Million)
Table 105. Middle East & Africa Biologic Medication in COVID-19 Consumption Value by Application (2018-2023) & (USD Million)
Table 106. Middle East & Africa Biologic Medication in COVID-19 Consumption Value by Application (2024-2029) & (USD Million)
Table 107. Middle East & Africa Biologic Medication in COVID-19 Consumption Value by Country (2018-2023) & (USD Million)
Table 108. Middle East & Africa Biologic Medication in COVID-19 Consumption Value by Country (2024-2029) & (USD Million)
Table 109. Biologic Medication in COVID-19 Raw Material
Table 110. Key Suppliers of Biologic Medication in COVID-19 Raw Materials
LIST OF FIGURES
Figure 1. Biologic Medication in COVID-19 Picture
Figure 2. Global Biologic Medication in COVID-19 Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Biologic Medication in COVID-19 Consumption Value Market Share by Type in 2022
Figure 4. Neutralizing Antibodies
Figure 5. Anti-inflammatory Drugs
Figure 6. Global Biologic Medication in COVID-19 Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Biologic Medication in COVID-19 Consumption Value Market Share by Application in 2022
Figure 8. COVID-19 Picture
Figure 9. Influenza Picture
Figure 10. Malaria Picture
Figure 11. Others Picture
Figure 12. Global Biologic Medication in COVID-19 Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Biologic Medication in COVID-19 Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Biologic Medication in COVID-19 Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Biologic Medication in COVID-19 Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Biologic Medication in COVID-19 Consumption Value Market Share by Region in 2022
Figure 17. North America Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Biologic Medication in COVID-19 Revenue Share by Players in 2022
Figure 23. Biologic Medication in COVID-19 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Biologic Medication in COVID-19 Market Share in 2022
Figure 25. Global Top 6 Players Biologic Medication in COVID-19 Market Share in 2022
Figure 26. Global Biologic Medication in COVID-19 Consumption Value Share by Type (2018-2023)
Figure 27. Global Biologic Medication in COVID-19 Market Share Forecast by Type (2024-2029)
Figure 28. Global Biologic Medication in COVID-19 Consumption Value Share by Application (2018-2023)
Figure 29. Global Biologic Medication in COVID-19 Market Share Forecast by Application (2024-2029)
Figure 30. North America Biologic Medication in COVID-19 Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Biologic Medication in COVID-19 Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Biologic Medication in COVID-19 Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Biologic Medication in COVID-19 Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Biologic Medication in COVID-19 Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Biologic Medication in COVID-19 Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 40. France Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Biologic Medication in COVID-19 Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Biologic Medication in COVID-19 Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Biologic Medication in COVID-19 Consumption Value Market Share by Region (2018-2029)
Figure 47. China Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 50. India Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Biologic Medication in COVID-19 Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Biologic Medication in COVID-19 Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Biologic Medication in COVID-19 Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Biologic Medication in COVID-19 Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Biologic Medication in COVID-19 Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Biologic Medication in COVID-19 Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 64. Biologic Medication in COVID-19 Market Drivers
Figure 65. Biologic Medication in COVID-19 Market Restraints
Figure 66. Biologic Medication in COVID-19 Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Biologic Medication in COVID-19 in 2022
Figure 69. Manufacturing Process Analysis of Biologic Medication in COVID-19
Figure 70. Biologic Medication in COVID-19 Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Biologic Medication in COVID-19 Picture
Figure 2. Global Biologic Medication in COVID-19 Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Biologic Medication in COVID-19 Consumption Value Market Share by Type in 2022
Figure 4. Neutralizing Antibodies
Figure 5. Anti-inflammatory Drugs
Figure 6. Global Biologic Medication in COVID-19 Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Biologic Medication in COVID-19 Consumption Value Market Share by Application in 2022
Figure 8. COVID-19 Picture
Figure 9. Influenza Picture
Figure 10. Malaria Picture
Figure 11. Others Picture
Figure 12. Global Biologic Medication in COVID-19 Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Biologic Medication in COVID-19 Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Biologic Medication in COVID-19 Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Biologic Medication in COVID-19 Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Biologic Medication in COVID-19 Consumption Value Market Share by Region in 2022
Figure 17. North America Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Biologic Medication in COVID-19 Revenue Share by Players in 2022
Figure 23. Biologic Medication in COVID-19 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Biologic Medication in COVID-19 Market Share in 2022
Figure 25. Global Top 6 Players Biologic Medication in COVID-19 Market Share in 2022
Figure 26. Global Biologic Medication in COVID-19 Consumption Value Share by Type (2018-2023)
Figure 27. Global Biologic Medication in COVID-19 Market Share Forecast by Type (2024-2029)
Figure 28. Global Biologic Medication in COVID-19 Consumption Value Share by Application (2018-2023)
Figure 29. Global Biologic Medication in COVID-19 Market Share Forecast by Application (2024-2029)
Figure 30. North America Biologic Medication in COVID-19 Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Biologic Medication in COVID-19 Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Biologic Medication in COVID-19 Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Biologic Medication in COVID-19 Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Biologic Medication in COVID-19 Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Biologic Medication in COVID-19 Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 40. France Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Biologic Medication in COVID-19 Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Biologic Medication in COVID-19 Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Biologic Medication in COVID-19 Consumption Value Market Share by Region (2018-2029)
Figure 47. China Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 50. India Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Biologic Medication in COVID-19 Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Biologic Medication in COVID-19 Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Biologic Medication in COVID-19 Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Biologic Medication in COVID-19 Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Biologic Medication in COVID-19 Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Biologic Medication in COVID-19 Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Biologic Medication in COVID-19 Consumption Value (2018-2029) & (USD Million)
Figure 64. Biologic Medication in COVID-19 Market Drivers
Figure 65. Biologic Medication in COVID-19 Market Restraints
Figure 66. Biologic Medication in COVID-19 Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Biologic Medication in COVID-19 in 2022
Figure 69. Manufacturing Process Analysis of Biologic Medication in COVID-19
Figure 70. Biologic Medication in COVID-19 Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
